Inhibits the growth of cancer cells through the downregulation of PI3K/Akt, STAT3, VEGF, NF-κB, the non-protein sulfhydryl pathway, lactate dehydrogenase, and creatine kinase. This evidence concerns the gene NFKB1 and cancer.